On the margins of the 142nd Session of the World Health Organization Executive Board (EB142), we developed innovative partnerships between governments, investment firms and the private sector to catalyze blended investment in innovations.

At this exclusive event co-hosted with UNAIDS, Johnson & Johnson, Center for Global Health and Development, we helped shape the external environment to better support research and development and enable proven and effective innovations to be easily brought to market, which, in turn, contributed to global and country-level efforts to achieve the Sustainable Development Goals.

This event will featured the Innovation to Impact Platform (I2I), which highlighted innovations that had been piloted and tested with committed investment capital up to $100 million. Through targeted demonstrations for investors and government ministers, the I2I Platform helped to create lasting partnerships between stakeholders, identify investment vehicles to fund promising opportunities, and incorporate policy and national government planning considerations to advance global health.